Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.

Yan, Li; Shu-Ying, Yang; Shan, Kang; Yip, Benjamin H K; Rong-Miao, Zhou; Na, Wang; Hai-Yan, Sun

Yan, Li; Shu-Ying, Yang; Shan, Kang; Yip, Benjamin H K; Rong-Miao, Zhou; Na, Wang; Hai-Yan, Sun.

Affiliation

Yan L; Hebei Medical University, Fourth Hospital, Shijiazhuang, 050011, China.

Pharmacogenomics ; 13(4): 419-27, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22329723

Subject(s)

Biomarkers, Pharmacological; DNA-Binding Proteins/genetics; Endonucleases/genetics; Genotype; Neoplasms, Glandular and Epithelial/genetics; Ovarian Neoplasms/genetics; Platinum/therapeutic use; Adult; Carcinoma, Ovarian Epithelial; China; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial/drug therapy; Ovarian Neoplasms/drug therapy; Polymorphism, Genetic; Prognosis; Survival Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Platinum / Neoplasms, Glandular and Epithelial / DNA-Binding Proteins / Endonucleases / Biomarkers, Pharmacological / Genotype Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2012 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google